Bruce & Co as of March 31, 2022
Portfolio Holdings for Bruce & Co
Bruce & Co holds 32 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amerco Common (UHAL) | 9.2 | $45M | 75k | 596.93 | |
Nextera Energy Common | 8.5 | $42M | 490k | 84.71 | |
Abbvie Common (ABBV) | 8.1 | $40M | 244k | 162.11 | |
Allstate Common (ALL) | 7.9 | $39M | 279k | 138.51 | |
CMS Energy Common (CMS) | 6.7 | $33M | 469k | 69.94 | |
Duke Energy Common (DUK) | 6.5 | $32M | 286k | 111.66 | |
Bausch Health Common | 6.5 | $32M | 1.4M | 22.85 | |
XEL Energy Common (XEL) | 6.1 | $30M | 413k | 72.17 | |
Pfizer Common (PFE) | 5.7 | $28M | 543k | 51.77 | |
Merck Common | 5.4 | $27M | 324k | 82.05 | |
Apple Common (AAPL) | 4.9 | $24M | 137k | 174.61 | |
At & T Common (T) | 4.5 | $22M | 922k | 23.63 | |
Abbott Common (ABT) | 4.1 | $20M | 168k | 118.36 | |
Paratek Cv 4.75% (Principal) | 3.0 | $15M | 17M | 0.88 | |
Ge Common | 2.0 | $9.5M | 104k | 91.50 | |
Avista Common (AVA) | 1.9 | $9.3M | 205k | 45.15 | |
Supernus Common (SUPN) | 1.5 | $7.2M | 222k | 32.32 | |
Newmont Common (NEM) | 1.1 | $5.2M | 65k | 79.45 | |
XM Sirius Common | 1.0 | $5.0M | 758k | 6.62 | |
Paratek Common | 0.9 | $4.6M | 1.6M | 2.97 | |
Edap Common (EDAP) | 0.8 | $4.1M | 566k | 7.25 | |
Acorda Theraputics Cv 6.0% (Principal) | 0.8 | $3.8M | 5.0M | 0.75 | |
Amryt Common | 0.5 | $2.6M | 315k | 8.26 | |
Ashland Common | 0.5 | $2.5M | 25k | 98.40 | |
Fate Theraputics Common (FATE) | 0.5 | $2.2M | 57k | 38.75 | |
Accelerate Diagnostic Cv 2.5% (Principal) | 0.4 | $2.0M | 3.0M | 0.66 | |
IGM Bioscience Common (IGMS) | 0.3 | $1.5M | 55k | 26.73 | |
Mannkind Common (MNKD) | 0.3 | $1.5M | 395k | 3.68 | |
Organon Common (OGN) | 0.2 | $1.1M | 32k | 34.91 | |
Viatris Common (VTRS) | 0.1 | $669k | 62k | 10.88 | |
Novavax Cv 3.75% (Principal) | 0.1 | $642k | 600k | 1.07 | |
Rli Common (RLI) | 0.1 | $269k | 2.4k | 112.08 |